Table 1.
Patient demographic and clinical characteristics
| No–mild NPDR (n=17) |
Moderate–severe NPDR (n=21) |
PDR (n=13) |
p Value | |
|---|---|---|---|---|
| Age, mean (SD) | 52.4 (10.6) | 47.6 (11.7) | 46.2 (12.9) | 0.32 |
| BCVA, mean (SD) | 0.10 (0.12) | 0.15 (0.16) | 0.25 (0.33) | 0.17 |
| HbA1c, mean (SD) | 7.40 (1.41) | 8.27 (1.47) | 8.90 (2.11) | 0.11 |
| Female gender, n (%) | 7 (41%) | 3 (14%) | 6 (46%) | 0.08 |
| HTN, n (%) | 7 (41%) | 12 (57%) | 8 (62%) | 0.56 |
| HLD, n (%) | 11 (65%) | 9 (43%) | 8 (62%) | 0.38 |
| DM type 1, n (%) | 4 (24%) | 7 (33%) | 4 (31%) | 0.86 |
| Insulin use, n (%) | 10 (56%) | 11 (52%) | 10 (77%) | 0.36 |
BCVA, best-corrected visual acuity; DM, diabetes mellitus; HbA1c, haemoglobin A1c; HLD, hyperlipidaemia; HTN, hypertension; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.